New Carcinogen Review Includes Alcohol and Second-Hand Smoke

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 4
Volume 7
Issue 4

RESEARCH TRIANGLE PARK, NC--Alcoholic beverages and environmental tobacco smoke top a list of eight things the National Toxicology Program recently announced it would review for listing in the federal government’s Ninth Report on Carcinogens, which will go to Congress in 1999.

RESEARCH TRIANGLE PARK, NC--Alcoholic beverages and environmental tobacco smoke top a list of eight things the National Toxicology Program recently announced it would review for listing in the federal government’s Ninth Report on Carcinogens, which will go to Congress in 1999.

The other six include particulates in diesel engine exhaust; isoprene, an element of natural rubber; methyl-t-butyl ether, an additive to unleaded gasoline; crystalline silica from mining, quarrying, stone-cutting, and related occupations; the sterilant ethylene oxide; and the element nickel and its compounds. The last two elements, both currently listed as "anticipated" human carcinogens, will be considered for designation as "known" human carcinogens.

Recent Videos
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
A simulation procedure helped to ascertain chemotherapy tolerability before administering radioembolization therapy for NETs with liver metastases.
The addition of radioembolization to radiosensitizing chemotherapy may help concurrently treat patients with liver tumors and disease outside the liver.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
4 experts are featured in this series.
4 experts are featured in this series.
According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.
7 experts are featured in this series.
Related Content